Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-04-28 @ 5:31 PM
Study NCT ID:
NCT01290302
Status:
COMPLETED
Last Update Posted:
2025-06-12
First Post:
2011-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza
Sponsor:
American Regent, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1AZA10001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None